ManagedCareCGM

Continuous Glucose Monitoring

Education for Managed Care, Pharmacy, and Payer Professionals

COVID-19 & CGM Education

Search
Generic filters

The Value of Continuous Glucose Monitoring during the COVID-19 Pandemic and New Era of Digital Healthcare

Free On-demand CE Activity:

Intended Audience: This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, registered nurses, and other managed health care professionals.

Credit Available: Up to 1.0 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

EDUCATIONAL OBJECTIVES

  • Describe the benefits of remote monitoring in the management of hospitalized patients with COVID-19 and dysglycemia
  • Assess the value of rtCGM in improving quality of care and reducing societal health-costs in a new era of digital health
  • Characterize the role of rtCGM as part of an employer-driven diabetes management strategy
  • Identify appropriate benefit design strategies to reduce healthcare system burden and improve quality, clinical, and economic outcomes

EXPERT FACULTY

Daniel DeSalvo, MD
Assistant Professor
Pediatric Endocrinologist
Baylor College of Medicine
Texas Children’s Hospital

Jeffrey Dunn, PharmD, MBA
(Formerly) Vice President, Clinical Strategy and Programs Industry Relations
Magellan Rx Management

Troy Ross, MSM
President & CEO
Mid-America Coalition on Health Care

For complete CE information and to register for this activity, please go to:
https://www.managedcarecgm.com/neweraofcgm/

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This activity is supported by an independent educational grant from Dexcom, Inc.


Clinical and Technology Innovations With Interoperable Real-Time CGM

Free On-demand CE Activity

Intended Audience: This activity is intended for diabetologists/endocrinologists, primary care physicians, obstetricians and gynecologists, nurses, nurse practitioners, and pharmacists.

Credit Available: Up to 0.25 credit hours of AMA PRA Category 1 CreditsTM), ABIM MOC points, ANCC Contact Hour(s), and knowledge-based ACPE (0.025 CEUs).

EDUCATIONAL OBJECTIVES

  • Upon completion of this activity, participants will:

    • Have increased knowledge regarding the
      • Data supporting use of real-time CGM (rtCGM) in various patients/settings in diabetes practice
      • Role of rtCGM in various patient types and diabetes practice settings
    • Have greater competence related to
      • Clinical use of rtCGM to improve patient outcomes in various patients/settings

EXPERT FACULTY

Shivani Agarwal, MD, MPH
Director, Supporting Emerging Adults With Diabetes (SEAD) Program, Fleischer Institute for Diabetes and Metabolism
NY-Regional Center for Diabetes Translational Research, Albert Einstein College of Medicine
Bronx, New York

Gregory P. Forlenza, MD
Assistant Professor
Barbara Davis Center for Diabetes
Aurora, Colorado

For complete CE information and to access the activity, please go to:
www.medscape.org/symposium/rtcgm-updates

Supported by an independent educational grant from Dexcom.


Real-Time CGM in the Hospital: Improving Management in the COVID-19 Pandemic

Free On-demand CE Activity

Intended Audience: Primary care physicians, diabetologists, endocrinologists, critical care specialists, and nurses.

Credit Available: Up to 0.5 credit hour available for Physicians (ACCME) and Nurses.

EDUCATIONAL OBJECTIVES

  • Need for enhanced glucose monitoring via continuous glucosemonitoring (CGM) in the hospital setting during coronavirus disease 2019 (COVID-19) pandemic
  • Strategies for effective use of real-time CGM (rtCGM) in the intensive care unit (ICU) and step-down settings during COVID-19

EXPERT FACULTY

Guillermo E. Umpierrez, MD
Professor of Medicine, Division of Endocrinology, Metabolism, Emory University School of Medicine
Chief, Diabetes and Endocrinology, Grady Memorial Hospital
Atlanta, Georgia

Shivani Agarwal, MD, MPH
Director, Supporting Emerging Adults With Diabetes (SEAD) Program, Fleischer Institute for Diabetes and Metabolism
NY-Regional Center for Diabetes Translational Research, Albert Einstein College of Medicine
Bronx, New York

Carol J. Levy, MD, CDE
Associate Professor of Medicine & Obstetrics, Director, Mount Sinai Diabetes Center and T1D Clinical Research
Icahn School of Medicine at Mount Sinai
New York, New York

For complete CE information and to access the activity, please go to:
www.medscape.org/roundtable/covid-diabetes-cgm-hospital

Supported by an independent educational grant from Dexcom.